Treatment with Recombinant Growth Hormone Is Associated with Modest Improvement in CD4 Lymphocyte Reconstitution in HIV-Infected Persons on Antiretroviral Therapy: Results of ACTG A5174-Reference-Cited by-同舟云学术

Treatment with Recombinant Growth Hormone Is Associated with Modest Improvement in CD4 Lymphocyte Reconstitution in HIV-Infected Persons on Antiretroviral Therapy: Results of ACTG A5174

Published:2010-04 Issue:4 Volume:26 Page:425-432
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Smith Kimberly¹,Zheng Lu²,Bosch Ronald²,Margolis David M.³,Tenorio Allan¹,Napolitano Laura⁴,Saag Michael⁵,Connick Elizabeth⁶,Gross Barry⁷,Francis Isaac⁷,Valdez Hernan⁸,Muurahainen Norma⁹,Stocker Vicky¹⁰,Pollard Richard¹¹

Affiliation:

1. Section of Infectious Diseases, Rush University Medical Center, Chicago, Illinois.

2. Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston Massachusetts.

3. Departments of Medicine, Microbiology & Immunology, Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

4. Department of Medicine, University of California–San Francisco, San Francisco, California.

5. Department of Medicine, University of Alabama, Birmingham, Alabama.

6. University of Colorado Health Sciences Center, Aurora, Colorado.

7. Department of Radiology, University of Michigan, Ann Arbor, Michigan.

8. Pfizer, Inc., New York, New York.

9. Serono, Inc., Rockland, Massachusetts.

10. Social and Scientific Systems, Inc., AACTG Operations Center, Bethesda, Maryland.

11. Department of Internal Medicine/Infectious Diseases, University of California Davis Health System, Sacramento, California.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2009.0052

Reference29 articles.

1. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

2. Rapid CD4+ T-cell turnover in HIV-1 infection: A paradigm revisited

3. HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

4. Immunologic Responses Associated with 12 Weeks of Combination Antiretroviral Therapy Consisting of Zidovudine, Lamivudine, and Ritonavir: Results of AIDS Clinical Trials Group Protocol 315

5. Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Canadian Survey of Research on HIV-1 Latency—Where Are We Now and Where Are We Heading?;Viruses;2024-02-01

2. (5R)-5-hydroxytriptolide for HIV immunological non-responders receiving ART: a randomized, double-blinded, placebo-controlled phase II study;The Lancet Regional Health - Western Pacific;2023-05

3. In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review;Clinical and Translational Science;2022-11-24

4. In vivo and in vitro evidence for growth hormone-like bioactivity of Rhizoma Anemarrhenae extract;Biomedicine & Pharmacotherapy;2022-09

5. Reconstitution of the immune system after hematopoietic stem cell transplantation;Hématologie;2018-01